Cofactor Genomics Commences First Predictive Immune Modeling Clinical Trial to Bridge Precision Medicine Gap for Immunotherapy
SAN FRANCISCO, Calif. – April 13, 2021 – Cofactor Genomics, the company bridging the precision medicine gap, today announced commencement of the first multicenter clinical trial of its [...]
New Data Published from Women & Infants Hospital Demonstrate Utility of Predictive Immune Modeling in Ovarian Cancer
PROVIDENCE, R.I. – March 8, 2021 (Reportable News)– Cofactor Genomics, the company bridging the precision medicine gap, announced today new data published in Frontiers in Oncology by Women & [...]
SAN FRANCISCO, Feb. 28, 2020 (CLINICAL OMICS) – A retrospective study among head and neck cancer patients found that a multivariate RNA biomarker test performed equally as standard PD-L1 [...]
SAN FRANCISCO, Dec. 16, 2019 (THE PATHOLOGIST) – Showcasing the latest techniques and technologies from industry innovators around the globe.
SAN FRANCISCO, Dec. 2, 2019 (GENENGNEWS) – Machine learning, says Cofactor Genomics, moves RNA-seq to RNA models, enables multidimensional biomarkers.